681 related articles for article (PubMed ID: 28077166)
1. Threonine
Moszczynski AJ; Yang W; Hammond R; Ang LC; Strong MJ
Acta Neuropathol Commun; 2017 Jan; 5(1):6. PubMed ID: 28077166
[TBL] [Abstract][Full Text] [Related]
2. Widespread neuronal and glial hyperphosphorylated tau deposition in ALS with cognitive impairment.
Yang W; Strong MJ
Amyotroph Lateral Scler; 2012 Feb; 13(2):178-93. PubMed ID: 22214313
[TBL] [Abstract][Full Text] [Related]
3. Detection of Alzheimer's disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau).
Gibbons GS; Kim SJ; Robinson JL; Changolkar L; Irwin DJ; Shaw LM; Lee VM; Trojanowski JQ
Acta Neuropathol Commun; 2019 Mar; 7(1):34. PubMed ID: 30832741
[TBL] [Abstract][Full Text] [Related]
4. Thr175-phosphorylated tau induces pathologic fibril formation via GSK3β-mediated phosphorylation of Thr231 in vitro.
Moszczynski AJ; Gohar M; Volkening K; Leystra-Lantz C; Strong W; Strong MJ
Neurobiol Aging; 2015 Mar; 36(3):1590-9. PubMed ID: 25573097
[TBL] [Abstract][Full Text] [Related]
5. Sporadic four-repeat tauopathy with frontotemporal lobar degeneration, Parkinsonism, and motor neuron disease: a distinct clinicopathological and biochemical disease entity.
Fu YJ; Nishihira Y; Kuroda S; Toyoshima Y; Ishihara T; Shinozaki M; Miyashita A; Piao YS; Tan CF; Tani T; Koike R; Iwanaga K; Tsujihata M; Onodera O; Kuwano R; Nishizawa M; Kakita A; Ikeuchi T; Takahashi H
Acta Neuropathol; 2010 Jul; 120(1):21-32. PubMed ID: 20140439
[TBL] [Abstract][Full Text] [Related]
6. Pathologic Thr
Moszczynski AJ; Strong W; Xu K; McKee A; Brown A; Strong MJ
Neurology; 2018 Jan; 90(5):e380-e387. PubMed ID: 29298849
[TBL] [Abstract][Full Text] [Related]
7. The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies.
Nijholt DA; van Haastert ES; Rozemuller AJ; Scheper W; Hoozemans JJ
J Pathol; 2012 Apr; 226(5):693-702. PubMed ID: 22102449
[TBL] [Abstract][Full Text] [Related]
8. Detection of Alzheimer Disease (AD)-Specific Tau Pathology in AD and NonAD Tauopathies by Immunohistochemistry With Novel Conformation-Selective Tau Antibodies.
Gibbons GS; Banks RA; Kim B; Changolkar L; Riddle DM; Leight SN; Irwin DJ; Trojanowski JQ; Lee VMY
J Neuropathol Exp Neurol; 2018 Mar; 77(3):216-228. PubMed ID: 29415231
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of Threonine 175 Tau in the Induction of Tau Pathology in Amyotrophic Lateral Sclerosis-Frontotemporal Spectrum Disorder (ALS-FTSD). A Review.
Moszczynski AJ; Hintermayer MA; Strong MJ
Front Neurosci; 2018; 12():259. PubMed ID: 29731706
[TBL] [Abstract][Full Text] [Related]
10. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
[TBL] [Abstract][Full Text] [Related]
11. Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies.
Pires G; McElligott S; Drusinsky S; Halliday G; Potier MC; Wisniewski T; Drummond E
Acta Neuropathol Commun; 2019 Dec; 7(1):195. PubMed ID: 31796108
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease.
Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B
Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546
[TBL] [Abstract][Full Text] [Related]
13. Tau exhibits unique seeding properties in globular glial tauopathy.
Chung DC; Carlomagno Y; Cook CN; Jansen-West K; Daughrity L; Lewis-Tuffin LJ; Castanedes-Casey M; DeTure M; Dickson DW; Petrucelli L
Acta Neuropathol Commun; 2019 Mar; 7(1):36. PubMed ID: 30845985
[TBL] [Abstract][Full Text] [Related]
14. αB-crystallin and HSP27 in glial cells in tauopathies.
López-González I; Carmona M; Arregui L; Kovacs GG; Ferrer I
Neuropathology; 2014 Dec; 34(6):517-26. PubMed ID: 24985029
[TBL] [Abstract][Full Text] [Related]
15. Pathological tau deposition in Motor Neurone Disease and frontotemporal lobar degeneration associated with TDP-43 proteinopathy.
Behrouzi R; Liu X; Wu D; Robinson AC; Tanaguchi-Watanabe S; Rollinson S; Shi J; Tian J; Hamdalla HH; Ealing J; Richardson A; Jones M; Pickering-Brown S; Davidson YS; Strong MJ; Hasegawa M; Snowden JS; Mann DM
Acta Neuropathol Commun; 2016 Mar; 4():33. PubMed ID: 27036121
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
17. Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression.
Ferrer I; López-González I; Carmona M; Arregui L; Dalfó E; Torrejón-Escribano B; Diehl R; Kovacs GG
J Neuropathol Exp Neurol; 2014 Jan; 73(1):81-97. PubMed ID: 24335532
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
19. A peculiar constellation of tau pathology defines a subset of dementia in the elderly.
Kovacs GG; Molnár K; László L; Ströbel T; Botond G; Hönigschnabl S; Reiner-Concin A; Palkovits M; Fischer P; Budka H
Acta Neuropathol; 2011 Aug; 122(2):205-22. PubMed ID: 21437732
[TBL] [Abstract][Full Text] [Related]
20. Sporadic Pick's disease: a tauopathy characterized by a spectrum of pathological tau isoforms in gray and white matter.
Zhukareva V; Mann D; Pickering-Brown S; Uryu K; Shuck T; Shah K; Grossman M; Miller BL; Hulette CM; Feinstein SC; Trojanowski JQ; Lee VM
Ann Neurol; 2002 Jun; 51(6):730-9. PubMed ID: 12112079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
